ID   ITPR2_RAT               Reviewed;        2701 AA.
AC   P29995; Q99P56;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   02-OCT-2024, entry version 180.
DE   RecName: Full=Inositol 1,4,5-trisphosphate-gated calcium channel ITPR2 {ECO:0000305};
DE   AltName: Full=IP3 receptor isoform 2;
DE            Short=IP3R 2;
DE            Short=InsP3R2;
DE   AltName: Full=Inositol 1,4,5-trisphosphate receptor type 2;
DE   AltName: Full=Type 2 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 2 InsP3 receptor;
GN   Name=Itpr2 {ECO:0000312|RGD:69649};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANTS.
RC   TISSUE=Brain;
RX   PubMed=1655411; DOI=10.1002/j.1460-2075.1991.tb04882.x;
RA   Suedhof T.C., Newton C.A., Archer B.T. III, Ushkaryov Y.A., Mignery G.A.;
RT   "Structure of a novel InsP3 receptor.";
RL   EMBO J. 10:3199-3206(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Magnino F., Dufour J.-F.;
RT   "New rat IP3R isoform 2 sequence.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=10620513; DOI=10.1042/bj3450357;
RA   Adkins C.E., Morris S.A., De Smedt H., Sienaert I., Toeroek K.,
RA   Taylor C.W.;
RT   "Ca2+-calmodulin inhibits Ca2+ release mediated by type-1, -2 and -3
RT   inositol trisphosphate receptors.";
RL   Biochem. J. 345:357-363(2000).
RN   [4]
RP   INTERACTION WITH TRPC4.
RX   PubMed=11163362; DOI=10.1016/s0014-5793(00)02362-0;
RA   Mery L., Magnino F., Schmidt K., Krause K.-H., Dufour J.-F.;
RT   "Alternative splice variants of hTrp4 differentially interact with the C-
RT   terminal portion of the inositol 1,4,5-trisphosphate receptors.";
RL   FEBS Lett. 487:377-383(2001).
RN   [5]
RP   SUBUNIT, AND INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K., Haeseleer F.,
RA   Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [6]
RP   PHOSPHORYLATION AT SER-150, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS
RP   OF SER-150.
RX   PubMed=23019322; DOI=10.1074/jbc.m112.374058;
RA   Maxwell J.T., Natesan S., Mignery G.A.;
RT   "Modulation of inositol 1,4,5-trisphosphate receptor type 2 channel
RT   activity by Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated
RT   phosphorylation.";
RL   J. Biol. Chem. 287:39419-39428(2012).
RN   [7]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.m113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from proteolytic
RT   cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
CC   -!- FUNCTION: Inositol 1,4,5-trisphosphate-gated calcium channel that upon
CC       inositol 1,4,5-trisphosphate binding transports calcium from the
CC       endoplasmic reticulum lumen to cytoplasm (PubMed:10620513,
CC       PubMed:1655411, PubMed:23019322). Exists in two states; a long-lived
CC       closed state where the channel is essentially 'parked' with only very
CC       rare visits to an open state and that ligands facilitate the transition
CC       from the 'parked' state into a 'drive' mode represented by periods of
CC       bursting activity (By similarity). {ECO:0000250|UniProtKB:Q9Z329,
CC       ECO:0000269|PubMed:10620513, ECO:0000269|PubMed:1655411,
CC       ECO:0000269|PubMed:23019322}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:10620513,
CC         ECO:0000269|PubMed:23019322};
CC   -!- ACTIVITY REGULATION: Inositol 1,4,5-trisphosphate-gated calcium channel
CC       activity is inhibited by CALM1 in a calcium-dependent manner
CC       (PubMed:10620513). Inositol 1,4,5-trisphosphate-gated calcium channel
CC       activity is increased by cAMP that occurs independently of PKA
CC       activation. ATP and cytosolic calcium modulate the open probability
CC       (Po) predominantly by facilitating extended 'bursting' activity of the
CC       channel (By similarity). {ECO:0000250|UniProtKB:Q9Z329,
CC       ECO:0000269|PubMed:10620513}.
CC   -!- SUBUNIT: Homotetramer (PubMed:12032348). Interacts with CABP1
CC       (PubMed:12032348). Interacts with BOK; regulates ITPR2 expression
CC       (PubMed:23884412). Interacts with BCL2L10 (By similarity). Interacts
CC       with TRPC4 (PubMed:11163362). Interacts with CHGA and CHGB (By
CC       similarity). {ECO:0000250|UniProtKB:Q14571,
CC       ECO:0000250|UniProtKB:Q8WN96, ECO:0000269|PubMed:11163362,
CC       ECO:0000269|PubMed:12032348, ECO:0000269|PubMed:23884412}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9Z329}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q8WN96}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Forms clusters on endoplasmic reticulum membrane
CC       upon inositol 1,4,5-trisphosphate binding.
CC       {ECO:0000250|UniProtKB:Q9Z329}.
CC   -!- PTM: Phosphorylation by CaMK2 on Ser-150 significantly decreases the
CC       channel open probability. {ECO:0000269|PubMed:23019322}.
CC   -!- PTM: Phosphorylation by cAMP-dependent PKA on Ser-937 increases calcium
CC       release. {ECO:0000250|UniProtKB:Q9Z329}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61677; CAA43852.1; -; mRNA.
DR   EMBL; AF329470; AAK11622.1; -; mRNA.
DR   PIR; S17796; S17796.
DR   RefSeq; NP_112308.1; NM_031046.3.
DR   SMR; P29995; -.
DR   BioGRID; 249575; 2.
DR   IntAct; P29995; 2.
DR   STRING; 10116.ENSRNOP00000047905; -.
DR   TCDB; 1.A.3.2.1; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; P29995; -.
DR   PhosphoSitePlus; P29995; -.
DR   jPOST; P29995; -.
DR   PaxDb; 10116-ENSRNOP00000047905; -.
DR   GeneID; 81678; -.
DR   KEGG; rno:81678; -.
DR   UCSC; RGD:69649; rat.
DR   AGR; RGD:69649; -.
DR   CTD; 3709; -.
DR   RGD; 69649; Itpr2.
DR   eggNOG; KOG3533; Eukaryota.
DR   InParanoid; P29995; -.
DR   OrthoDB; 5480299at2759; -.
DR   PhylomeDB; P29995; -.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:P29995; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:RGD.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0030667; C:secretory granule membrane; IBA:GO_Central.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:RGD.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0015278; F:intracellularly gated calcium channel activity; ISO:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 2.80.10.50; -; 2.
DR   Gene3D; 1.25.10.30; IP3 receptor type 1 binding core, RIH domain; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_IP3_receptor.
DR   InterPro; IPR035910; RyR/IP3R_RIH_dom_sf.
DR   PANTHER; PTHR45816:SF3; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; 1.
DR   PANTHER; PTHR45816; MIR DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF100909; IP3 receptor type 1 binding core, domain 2; 2.
DR   SUPFAM; SSF82109; MIR domain; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   ATP-binding; Calcium; Calcium channel; Calcium transport;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   CHAIN           1..2701
FT                   /note="Inositol 1,4,5-trisphosphate-gated calcium channel
FT                   ITPR2"
FT                   /id="PRO_0000153926"
FT   TOPO_DOM        1..2227
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2228..2248
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2249..2260
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2261..2281
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2282..2284
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2285..2305
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2306..2307
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2308..2328
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2329..2351
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2352..2372
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2373..2394
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2395..2415
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2416..2521
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2522..2542
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2543..2701
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          112..166
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          173..223
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          231..287
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          294..357
FT                   /note="MIR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          378..434
FT                   /note="MIR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   REGION          1134..1174
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2676..2701
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1156..1174
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         265
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         267
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         268
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         269
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         503
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         507
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         510
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         567
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         568
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         569
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         744
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1124
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1127
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1930
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1994
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2044
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2177
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2562
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2562
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2563
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2565
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2582
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2584
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2587
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2587
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2588
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2589
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2605
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         150
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:23019322"
FT   MOD_RES         937
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z329"
FT   MOD_RES         1160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14571"
FT   MOD_RES         1709
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z329"
FT   MOD_RES         2607
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z329"
FT   MOD_RES         2636
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z329"
FT   VARIANT         689
FT                   /note="D -> H"
FT   VARIANT         1013
FT                   /note="G -> C"
FT   VARIANT         1256
FT                   /note="L -> P"
FT   VARIANT         2384
FT                   /note="V -> I"
FT   VARIANT         2694
FT                   /note="E -> V"
FT   MUTAGEN         150
FT                   /note="S->A: Loss of phosphorylation by CaMK2. Does not
FT                   affect Inositol 1,4,5-trisphosphate-sensitive calcium-
FT                   release channel activity."
FT                   /evidence="ECO:0000269|PubMed:23019322"
FT   MUTAGEN         150
FT                   /note="S->E: Decreases Inositol 1,4,5-trisphosphate-
FT                   sensitive calcium-release channel activity."
FT                   /evidence="ECO:0000269|PubMed:23019322"
FT   CONFLICT        119
FT                   /note="K -> N (in Ref. 2; AAK11622)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="H -> R (in Ref. 2; AAK11622)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        943
FT                   /note="W -> V (in Ref. 2; AAK11622)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1692
FT                   /note="S -> G (in Ref. 2; AAK11622)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2556
FT                   /note="K -> E (in Ref. 2; AAK11622)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2701 AA;  307058 MW;  42BF7F1024335984 CRC64;
     MSDKMSSFLY IGDIVSLYAE GSVNGFISTL GLVDDRCVVH PEAGDLTNPP KKFRDCLFKV
     CPMNRYSAQK QYWKAKQAKQ GNHTEAALLK KLQHAAELEQ KQNESENRKL LGEIVKYSKV
     IQLLHIKSNK YLTVNKRLPA LLEKNAMRVS LDAAGNEGSW FYIHPFWKLR SEGDNIVVGD
     KVVLMPVNAG QPLHASNVEL LDNPGCKEVN AVNCNTSWKI TLFMKFSSYR EDVLKGGDVV
     RLFHAEQEKF LTCDDYEKKQ HIFLRTTLRQ SATSATSSKA LWEIEVVHHD PCRGGAGQWN
     SLFRFKHLAT GNYLAAELNP DYRDAQNEGK TVRDGELPTS KKKHQAGEKI MYTLVSVPHG
     NDIASLFELD ATTLQRADCL VPRNSYVRLR HLCTNTWVTS TSIPIDTEEE RPVMLKIGTC
     QTKEDKEAFA IVCVPLSEVR DLDFANDANK VLATTVKKLE NGSITQNERR FVTKLLEDLI
     FFVADVTNNG QDVLDVVITK PNRERQKLMR EQNILAQVFG ILKAPFKEKA GEGSMLRLED
     LGDQRYAPYK YVLRLCYRVL RHSQQDYRKN QEYIAKNFCV MQSQIGYDIL AEDTITALLH
     NNRKLLEKHI TAKEIETFVS LLRRNREPRF LDYLSDLCVS NSTAIPVTQE LICKFMLSPG
     NADILIQTKL VSMQVENPME SSILPDDIDD EEVWLYWIDS NKEPHGKAIR HLAQEAREGT
     KADLEVLTYY RYQLNLFARM CLDRQYLAIN QISTQLSVDL ILRCVSDESL PFDLRASFCR
     LMLHMHVDRD PQESVVPVRY ARLWTEIPTK ITIHEYDSIT DSSRNDMKRK FALTMEFVEE
     YLKEVVNQPF PFGDKEKNKL TFEVVHLARN LIYFGFYSFS ELLRLTRTLL AILDIVQAPM
     SSYFERLSKF QDGSNNVMRT IHGVGEMMTQ MVLSRGSIFP VSWPDAQPSV HPSKQASPGE
     QEDVTVMDTK LKVIEILQFI LSVRLDYRIS YMLSIYKKEF GENDGNGDPS ASGTPETLLP
     SALVPDIDEI AAQAETMFAG RKEKTPVQLD DEGGRTFLRV LIHLIMHDYA PLLSGALQLL
     FKHFSQRAEV LQAFKQVQLL VSNQDVDNYK QIKADLDQLR LTVEKSELWV EKSGSYENGD
     MGEGQAKGGE EANEESNLLS PVQDGAKTPQ IDSNKGNNYR IVKEILIRLS KLCVQNKKCR
     NQHQRLLKNM GAHSVVLDLL QIPYEKTDEK MNEVMDLAHT FLQNFCRGNP QNQVLLHKHL
     NLFLTPGLLE AETMRHIFMN NYHLCNEISE RVVQHFVHCI ETHGRHVEYL RFLQTIVKAD
     GKYVKKCQDM VMTELINGGE DVLIFYNDRA SFPILLNMMC SERARGDESG PLAYHITLVE
     LLAACTEGKN VYTEIKCNSL LPLDDIVRVV THDDCIPEVK IAYVNFVNHC YVDTEVEMKE
     IYTSNHIWKL FENFLVDMAR VCNTTTDRKH ADTFLERCVT ESVMNIVSGF FNSPFSDNST
     SLQTHQPVFI QLLQSAFRIY NCTWPNPAQK ASVESCIRAL AEVAKNRGIA IPVDLDSQVN
     TLFMKNHSST VQRAAMGWRL SARSGPRFKE ALGGPAWDYR NIIEKLQDVV ASLEQQFSPM
     MQAEFSVLVD VLYSPELLFP EGSDARIRCG AFMSKLINHT KKLMEKEEKL CIKILQTLRE
     MLEKKDSFME ESSTLRKILL NRYFKGDHSV GVNGPLSGAY AKTAQVGGGF TGQDADKTGI
     SMSDIQCLLD KEGASELVID VIVNTKNDRI FSEGILLGIA LLEGGNTQTQ NSFYQQLHEQ
     KKSEKFFKVL YDRMKAAQKE IRSTVTVNTI DLGSKKREED SDLMALGPRM RVRDSSLHLK
     EGMKGQLTEA SSATSKAYCV YRREMDPDID TMCPGQEAGS AEEKSAEEVT MSPAITIMRP
     ILRFLQLLCE NHNRELQNFL RNQNNKTNYN LVCETLQFLD CICGSTTGGL GLLGLYINEK
     NVALVNQTLE SLTEYCQGPC HENQTCIATH ESNGIDIIIA LILSDINPLG KYRMDLVLQL
     KNNASKLLLA IMESRHDSEN AERILFNMRP KELVDVMKNA YNQGLECNHG DEEGGDDGVS
     PKDVGHNIYI LAHQLARHNK LLQQMLKPGS DPEEGDEALK YYANHTAQIE IVRHDRTMEQ
     IVFPVPNICE FLTRESKYRV FNTTERDEQG SKVNDFFQQT EDLYNEMKWQ KKIRNNPALF
     WFSRHISLWG SISFNLAVFI NLAVALFYPF GDDGDEGTLS PLFSALLWVA VAICTSMLFF
     FSKPVGIRPF LVSIMLRSIY TIGLGPTLIL LGAANLCNKI VFLVSFVGNR GTFTRGYRAV
     ILDMAFLYHV AYVLVCMLGL FVHEFFYSFL LFDLVYREET LLNVIKSVTR NGRSIILTAV
     LALILVYLFS IIGFLFLKDD FTMEVDRLKN RTPVTGNDGV PTMTLTSMLG TCPKENCSPT
     IPSSNAAGEG GEDGIERTCD TLLMCIVTVL NQGLRNGGGV GDVLRRPSKD EPLFAARVVY
     DLLFFFIVII IVLNLIFGVI IDTFADLRSE KQKKEKILKT TCFICGLERD KFDNKTVSFE
     EHIKSEHNMW HYLYFIVLVK VKDPTEYTGP ESYVAQMITE KNLDWFPRMR AMSLVSNEGD
     SEQNEIRNLQ EKLESTMSLV KQLSGQLAEL KEQMTEQRKN KQRLGFLGSN TPHENHHMPP
     H
//
